|
|
|
|
 |
Gen-Probe to Webcast Two Upcoming Investor Presentations |
| Companies mentioned in this article: |
|
Gen-Probe |
|
| 5/9/2008 @ 6:21 AM
print this article -
email to a friend -
join our eNewsletter
|
 |
Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Bank of America 2008 Health Care Conference in Las Vegas on May 13, 2008 at approximately 8 a.m. Pacific time (11 a.m. Eastern time) and at the Baird Growth Stock Conference in Chicago on May 14, 2008 at approximately 1:20 p.m. Central time (2:20 p.m. Eastern time). The presentations are scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at www.gen-probe.com/. The webcasts will be available for 30 days following the event.
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to www.gen-probe.com/. |
| BioTech / BioMedical / Medical |
|
|
| |
| Thursday, July 24, 2008 |
 |
|
Cancer Treatment Application of the Aethlon Hemopurifier Published in Journal of Translational Medicine Posted 8:21 AM PST
|
| |
| Wednesday, July 23, 2008 |
|
|
Duska Therapeutics Submits Phase 3 ATPace Protocol to FDA for Comment Posted 7:20 AM PST
Optimer Pharmaceuticals Completes Enrollment in OPT-80 Phase 3 Clinical Trial in Patients with Clostridium difficile Infection Posted 6:56 AM PST
Brendan Technologies CTO To Make Presentation to Regulatory Organization on Drug Release Testing Posted 6:54 AM PST
|
| |
| Tuesday, July 22, 2008 |
|
|
Helicon Study of HT-0712 on Primate Memory Formation Reveals Significant Enhancement Posted 9:34 PM PST
Vical Receives $1 Million Milestone Payment From AnGes MG for Angiogenesis Program Posted 7:19 AM PST
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models Posted 7:18 AM PST
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products Posted 7:01 AM PST
|
| |
| Monday, July 21, 2008 |
|
|
Abingdon Life Sciences, Inc. Announces Opening of Office in Carlsbad Posted 8:52 AM PST
Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company Posted 8:51 AM PST
Cardium Completes Registered Direct Investment Posted 8:44 AM PST
|
| |
| Thursday, July 17, 2008 |
|
|
Ardea to Present Data on Lead HIV Candidate, RDEA806, at XVII International AIDS Conference Posted 7:24 AM PST
International Stem Cell Corporation and Novocell, Inc. Collaborate to Test Human Parthenogenetic Stem Cells for production of Pancreatic Islet Cells that may be useful in the Treatment of Diabetes Posted 6:54 AM PST
|
| |
| Wednesday, July 16, 2008 |
|
|
Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah Posted 3:10 PM PST
Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease Posted 6:06 AM PST
Inovio Biomedical’s First Proprietary DNA Vaccine Achieves 100% Protection Against Avian Flu in Pre-Clinical Testing Posted 5:57 AM PST
Cytori Receives U.S. Patent Allowance for Protecting Cosmetic & Reconstructive Surgery Product Line Posted 5:56 AM PST
Hollis-Eden Pharmaceuticals Commences Phase II Clinical Trial with TRIOLEX (HE3286) in Type-2 Diabetes Patients; Expands Sites to Accelerate Enrollment Posted 5:51 AM PST
Optimer Pharmaceuticals Announces Positive Results in Prulifloxacin Phase 3 Study Posted 5:50 AM PST
|
| |
| Tuesday, July 15, 2008 |
|
|
Favrille Announces Receipt of Nasdaq Letters Posted 5:09 PM PST
PURE Bioscience Announces Distribution Agreement With Orchem Corporation Posted 5:05 PM PST
South Miami Hospital Goes Live with CliniComp’s Essentris in All Perinatal Areas Posted 6:30 AM PST
|
| |
| Monday, July 14, 2008 |
|
|
Cytori Sells First European Union StemSource Bank; Industry Leading Biohellenika of Greece Acquires Exclusive Rights Posted 3:00 PM PST
Asymtek’s New DispenseJet DJ-9500 is up to Ten Times Faster than Needle Dispensers in High-Volume Underfill and LED Silicone Applications Posted 2:57 PM PST
Vical to Present Phase 1 Data for Vaxfectin -Formulated Pandemic Influenza DNA Vaccines Posted 6:03 AM PST
|
| |
| Friday, July 11, 2008 |
|
|
Invitrogen to Integrate Brendan Technologies’ Advanced Analytical Software into Protein Analysis Solutions Posted 7:44 AM PST
|
|
|
|
|
|
FreshNews.com Jobs Change DAILY
We Have 5,000 + Job Listings! Open Your FREE Account
Employers or Job Searchers Get Started Now! Click Here
|
